Last10K.com

Anavex Life Sciences Corp. (AVXL) SEC Filing 8-K Material Event for the period ending Friday, March 10, 2023

Anavex Life Sciences Corp.

HISTORY TOOLS
CIK: 1631408 Ticker: AVXL

View differences made from one to another to evaluate Anavex Life Sciences Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Anavex Life Sciences Corp..

Continue

Assess how Anavex Life Sciences Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Anavex Life Sciences Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover
Ticker: AVXL
CIK: 1314052
Form Type: 8-K Corporate News
Accession Number: 0001731122-23-000348
Submitted to the SEC: Fri Mar 10 2023 6:32:56 PM EST
Accepted by the SEC: Mon Mar 13 2023
Period: Friday, March 10, 2023
Industry: Commercial Physical And Biological Research
Events:
  1. Regulated Disclosure

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/avxl/0001731122-23-000348.htm